Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
(-)-propranolol | 3187 | None | 44 | Human | Binding | AC50 | = | 20610.10 | 4.69 | - | 34 | Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay | ChEMBL | 259.2 | 6 | 2 | 3 | 2.58 | CC(C)NC[C@H](O)COc1cccc2ccccc12 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
5-oxo-1-2-4-oxadiazol biphenyl | 150 | None | 0 | Rat | Binding | pKi | = | - | 8.99 | - | 1 | Unclassified | Guide to Pharmacology | 423.2 | 9 | 2 | 5 | 3.69 | CCC[C@@H](C(=O)O)N(Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1)C(=O)CC | https://pubmed.ncbi.nlm.nih.gov/22410249 | |
[Sar1,Ala8]Ang-II | 3479 | None | 0 | Human | Binding | pKd | = | - | 9.05 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/11901215 | |
[Sar1,Cha4]Ang-II | 3480 | None | 0 | Rat | Binding | pKd | = | - | 7.12 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/11901215 | |
[Sar1,Cha4]Ang-II | 3480 | None | 0 | Rat | Binding | pKd | = | - | 7.12 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/10066768 | |
[Sar1,Cha8]Ang-II | 3481 | None | 0 | Rat | Binding | pKd | = | - | 9.33 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/11901215 | |
[Sar1,Cha8]Ang-II | 3481 | None | 0 | Rat | Binding | pKd | = | - | 9.33 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/10066768 | |
[Sar1,Gly4,Gly8]Ang-II | 3483 | None | 0 | Human | Binding | pKd | = | - | 6.51 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/11901215 | |
[Sar1,Ile4,Ile8]Ang-II | 3484 | None | 0 | Human | Binding | pKd | = | - | 6.51 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12949261 | |
[Sar1,Ile8]Ang-II | 3485 | None | 0 | Human | Binding | pKd | = | - | 9.43 | - | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/11901215 | |
[Val5] - ANGIOTENSIN II | 211801 | None | 28 | Human | Binding | Kd | = | 1.60 | 8.80 | - | 1 | Binding affinity to human AT1 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/acs.jmedchem.8b00435 | |
ALFACALCIDOL | 53539 | None | 37 | Human | Binding | AC50 | = | 8400.00 | 5.08 | - | 2 | Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay | ChEMBL | 400.3 | 6 | 2 | 2 | 6.59 | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
amisulpride | 400 | 3H-angiotensin II | 72 | Human | Binding | pKi | = | 10000.00 | 5.00 | -4365 | 53 | - | PDSP KiDatabase | 369.2 | 7 | 2 | 6 | 1.28 | CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC | - | |
amitriptyline | 401 | None | 38 | Human | Binding | AC50 | = | 1400.00 | 5.85 | - | 51 | Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay | ChEMBL | 277.2 | 3 | 0 | 1 | 4.17 | CN(C)CCC=C1c2ccccc2CCc2ccccc21 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
ANETHOLTRITHION | 63103 | None | 64 | Human | Binding | AC50 | = | 9299.90 | 5.03 | - | 10 | Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay | ChEMBL | 240.0 | 2 | 0 | 4 | 4.21 | COc1ccc(-c2cc(=S)ss2)cc1 | https://dx.doi.org/10.1038/s41467-023-40064-9 | |
angiotensin A | 418 | None | 0 | Human | Binding | pKi | = | - | 8.80 | 1 | 3 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/21464395 | |
angiotensin II | 419 | None | 38 | Human | Binding | IC50 | = | 10.20 | 7.99 | -1 | 5 | Displacement of [125-I]-[Sar1, Ile8] from recombinant human AT1R transfected in human HEK293 cells incubated for 2 hrs by liquid scintillation counter analysis | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmcl.2021.128086 | |
angiotensin II | 419 | None | 38 | Human | Binding | EC50 | = | 9.70 | 8.01 | -1 | 5 | Agonist activity at human AT1R expressed in HEK293 cells incubated for 60 mins by luminescence based beta-arrestin recruitment assay | ChEMBL | - | - | - | - | - | - | - | |
angiotensin II | 419 | None | 38 | Human | Binding | Ki | = | 0.16 | 9.80 | -1 | 5 | Displacement of [3H]-Angiotensin 2 from human placental AT1 receptor expressed in African green monkey COS7 cell membranes after 90 mins by gamma counting | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/acs.jmedchem.5b01495 | |
angiotensin II | 419 | None | 38 | Human | Binding | IC50 | = | 0.72 | 9.14 | -1 | 5 | Displacement of [3H]-Asp-{Nomega-[N-(4-propanoylaminobutyl)aminocarbonyl]}Arg-ValTyr-Ile-His-Pro-Phe-OH Tris(hydrotrifluoroacetate) from human AT1 receptor transfected in CHO cells co-expressing Galpha16-mtAEQ after 2 hrs by liquid scintillation counting | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/acs.jmedchem.5b01495 |
Showing 1 to 20 of 3,273 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
5-butyl-methyl immidazole carboxylate 30 | 132 | None | 0 | Human | Functional | pIC50 | = | - | 8.50 | - | 1 | Unclassified | Guide to Pharmacology | 348.2 | 7 | 1 | 3 | 4.95 | CCCCc1cnc(C(=O)O)n1Cc1ccc(-c2ccccc2C)cc1 | https://pubmed.ncbi.nlm.nih.gov/22889560 | |
5-butyl-methyl immidazole carboxylate 30 | 132 | None | 0 | Human | Functional | pA2 | = | - | 7.83 | - | 1 | Unclassified | Guide to Pharmacology | 348.2 | 7 | 1 | 3 | 4.95 | CCCCc1cnc(C(=O)O)n1Cc1ccc(-c2ccccc2C)cc1 | https://pubmed.ncbi.nlm.nih.gov/22889560 | |
5-oxo-1-2-4-oxadiazol biphenyl | 150 | None | 0 | Rat | Functional | pIC50 | = | - | 8.80 | - | 1 | Unclassified | Guide to Pharmacology | 423.2 | 9 | 2 | 5 | 3.69 | CCC[C@@H](C(=O)O)N(Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1)C(=O)CC | https://pubmed.ncbi.nlm.nih.gov/22410249 | |
[Sar1,Ile8]Ang-II | 3485 | None | 0 | Rat | Functional | pEC50 | = | - | 8.82 | - | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/7499361 | |
A77636 | 208 | None | 8 | Human | Functional | IC50 | = | 3130.24 | 5.50 | -1047 | 27 | GPCR PRESTO-Tango dose-response in antagonist mode with target: AGTR1 | ChEMBL | 329.2 | 2 | 3 | 4 | 3.25 | NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O | https://dx.doi.org/10.6019/CHEMBL5442687 | |
angiotensin A | 418 | None | 0 | Human | Functional | pEC50 | = | - | 8.17 | -56 | 3 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/21464395 | |
angiotensin A | 418 | None | 0 | Rat | Functional | pIC50 | = | - | 9.54 | -2 | 3 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/17138938 | |
angiotensin II | 419 | None | 38 | Human | Functional | pIC50 | = | - | 9.15 | -5 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/10193788 | |
angiotensin II | 419 | None | 38 | Human | Functional | pIC50 | = | 9.30 | 8.03 | -5 | 5 | None | Drug Central | - | - | - | - | - | - | - | |
angiotensin II | 419 | None | 38 | Human | Functional | EC50 | = | 2.60 | 8.59 | -5 | 5 | Agonist activity at human AT1R expressed in HEK293 cells incubated for 30 mins by IP1 accumulation assay | ChEMBL | - | - | - | - | - | - | - | |
angiotensin II | 419 | None | 38 | Human | Functional | EC50 | = | 0.49 | 9.31 | -5 | 5 | Agonist activity at human AT1 receptor transfected in CHO cells co-expressing Galpha16-mtAEQ assessed as induction of intracellular Ca2+ mobilization by bioluminescence assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/acs.jmedchem.5b01495 | |
angiotensin II | 419 | None | 38 | Human | Functional | EC50 | = | 0.52 | 9.28 | -5 | 5 | Agonist activity at human AT1 receptor transfected in CHO cells co-expressing Galpha16-mtAEQ assessed as induction of intracellular Ca2+ mobilization by bioluminescence assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/acs.jmedchem.5b01495 | |
angiotensin II | 419 | None | 38 | Rat | Functional | EC50 | = | 1.30 | 8.89 | -6 | 5 | Agonist activity at rat AT1aR expressed in HEK293 cells incubated for 30 mins by IP1 accumulation assay | ChEMBL | - | - | - | - | - | - | - | |
angiotensin III | 420 | None | 0 | Human | Functional | pIC50 | = | - | 8.45 | -2 | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | - | |
angiotensin IV | 421 | None | 29 | Human | Functional | pEC50 | = | - | 5.90 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12006574 | |
ANGIOTENSIN-II | 212873 | None | 5 | Rat | Functional | EC50 | = | 7.30 | 8.14 | -50 | 3 | Agonist activity at rat AT1aR expressed in HEK293 cells incubated for 30 mins by IP1 accumulation assay | ChEMBL | - | - | - | - | - | - | - | |
ANGUSTIBALIN | 185576 | None | 17 | Human | Functional | IC50 | = | 21974.00 | 4.66 | -4 | 2 | PUBCHEM_BIOASSAY: Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor. (Class of assay: confirmatory) [Related pubchem assays: 2569, 2521 ] | ChEMBL | 304.1 | 1 | 0 | 5 | 1.82 | C=C1C(=O)O[C@@H]2C[C@@H](C)[C@@H]3C=CC(=O)[C@@]3(C)[C@@H](OC(C)=O)[C@H]12 | - | |
azilsartan | 560 | None | 64 | Human | Functional | pIC50 | = | - | 8.11 | 53 | 2 | Unclassified | Guide to Pharmacology | 456.1 | 7 | 2 | 7 | 4.19 | CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nc(=O)o[nH]2)cc1 | https://pubmed.ncbi.nlm.nih.gov/24742498 | |
azilsartan | 560 | None | 64 | Human | Functional | pIC50 | = | - | 8.11 | 53 | 2 | Unclassified | Guide to Pharmacology | 456.1 | 7 | 2 | 7 | 4.19 | CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nc(=O)o[nH]2)cc1 | https://pubmed.ncbi.nlm.nih.gov/24739538 | |
azilsartan medoxomil | 220221 | None | 0 | Human | Functional | pIC50 | = | 8.13 | 8.09 | -1 | 2 | None | Drug Central | 568.2 | 9 | 1 | 11 | 4.71 | CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1 | - |
Showing 1 to 20 of 823 entries